Literature DB >> 29185020

The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).

Wen-Jun Wei1,2, Zhong-Wu Lu1,2, Duo Wen1,2, Tian Liao1,2, Duan-Shu Li1,2, Yu Wang1,2, Yong-Xue Zhu1,2, Zhuo-Ying Wang1,2, Yi Wu1,2, Yu-Long Wang3,4, Qing-Hai Ji5,6.   

Abstract

BACKGROUND: Lymph node metastasis is important when evaluating the prognosis of patients with differentiated thyroid cancer (DTC). However, the current N-staging system cannot fully reflect the clinical significance of cervical lymph node metastasis in DTC. In this study, we employed Surveillance, Epidemiology, and End Results (SEER)-registered DTC cases with lymph node metastasis to determine whether the positive lymph node number (PLNN) could be used to improve stratification of patients in terms of survival.
METHODS: We used the SEER dataset to identify all DTC patients with at least one positive cervical lymph node who were examined between 1988 and 2008. Multivariable modeling was used to compare cancer-specific survival (CSS) and overall survival (OS) and to calculate different PLNN cutoff points.
RESULTS: In total, 14,359 pN + DTC patients identified in the SEER were included. In multivariate Cox regression analysis, the PLNN was significantly associated with both CSS and OS, whereas neither the lymph node ratio (LNR) nor the (numbers of) lymph nodes examined (LNE) were so associated. The highest C-index value (0.933) and the lowest AIC value (9362.687) obtained indicated that the PLNN better predicted the CSS of DTC than did the LNR or LNE. As the p values for both CSS and OS were minimized, and as the PLNN performed best when cases were grouped, PLNN cutoff points of 10 and 3/10 efficiently stratified DTC patients into two and three levels, respectively. Based on the 3/10 trichotomy, the benefits of radioactive iodine (RAI) treatment were evaluated for each group. Such treatment afforded about a 10% survival benefit in patients with more than 10 lymph node metastases.
CONCLUSIONS: Compared with the LNR and LNE under different statistical models, PLNN was superior in terms of DTC staging. A cutoff point of 3/10 was optimal for stratifying patients according to prognosis and was of clinical significance in terms of RAI treatment selection.

Entities:  

Mesh:

Year:  2018        PMID: 29185020     DOI: 10.1007/s00268-017-4343-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

2.  Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.

Authors:  Julio Ricarte-Filho; Ian Ganly; Michael Rivera; Nora Katabi; Weimin Fu; Ashok Shaha; R Michael Tuttle; James A Fagin; Ronald Ghossein
Journal:  Thyroid       Date:  2012-04-03       Impact factor: 6.568

3.  Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia.

Authors:  Soo Youn Cho; Tae Hyun Lee; Yun Hyi Ku; Hong Il Kim; Guk Haeng Lee; Min Joo Kim
Journal:  Surgery       Date:  2014-10-14       Impact factor: 3.982

4.  Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer.

Authors:  Andreas Machens; Henning Dralle
Journal:  J Clin Endocrinol Metab       Date:  2012-09-27       Impact factor: 5.958

5.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

6.  An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma.

Authors:  Shannon H Beal; Steven L Chen; Philip D Schneider; Steve R Martinez
Journal:  Am Surg       Date:  2010-01       Impact factor: 0.688

7.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

8.  Impact of lymph node ratio on survival in papillary thyroid cancer.

Authors:  David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2012-12-23       Impact factor: 5.344

9.  Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection.

Authors:  Brian Hung-Hin Lang; Kai Pun Wong; Koon Yat Wan; Chung-Yau Lo
Journal:  Ann Surg Oncol       Date:  2011-10-12       Impact factor: 5.344

Review 10.  Survival analysis part IV: further concepts and methods in survival analysis.

Authors:  T G Clark; M J Bradburn; S B Love; D G Altman
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

View more
  4 in total

1.  Development and validation of prognostic nomograms for medullary thyroid cancer.

Authors:  Yong-Jun Guan; Shi-Ying Fang; Lin-Lin Chen; Zheng-Dong Li
Journal:  Onco Targets Ther       Date:  2019-03-27       Impact factor: 4.147

2.  Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System.

Authors:  Zeming Liu; Sichao Chen; Yihui Huang; Di Hu; Min Wang; Wei Wei; Chao Zhang; Wen Zeng; Liang Guo
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

3.  The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.

Authors:  Jia-Qian Hu; Duo Wen; Ben Ma; Ting-Ting Zhang; Tian Liao; Xiao Shi; Yu-Long Wang; Yong-Xue Zhu; Yu Wang; Wen-Jun Wei; Qing-Hai Ji
Journal:  Cancer Med       Date:  2019-12-18       Impact factor: 4.452

4.  Large-Volume Lateral Lymph Node Metastasis Predicts Worse Prognosis in Papillary Thyroid Carcinoma Patients With N1b.

Authors:  Luying Gao; Xiaoyi Li; Yu Xia; Ruifeng Liu; Chunhao Liu; Xinlong Shi; Yanjiao Wu; Liyuan Ma; Yuxin Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-02       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.